1 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California.
2 Nuclear Medicine, Centre Hospitalier de l'Université de Montréal Centre de Recherche, Université de Montréal, Montréal, Québec, Canada.
3 Nuclear Medicine Department, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
4 Department of Hematology/Oncology, UCLA, Los Angeles, California.
5 Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, California.
6 Department of Nuclear Medicine, Henri Becquerel Cancer Center, and QuantIF-LITIS, University of Rouen, Rouen, France; and.
7 Department of Radiology, UCLA, Los Angeles, California.
8 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; jcalais@mednet.ucla.edu.